Literature DB >> 15105448

The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer.

Natalia L Komarova1, Dominik Wodarz.   

Abstract

Many cancers are characterized by chromosomal instability (CIN). This phenotype involves the deletion and duplication of chromosomes or chromosome parts and results in a high degree of aneuploidy. The role of CIN for cancer progression is a very important, yet unresolved question. It has been argued that CIN contributes to cancer initiation because chromosome loss can unmask a mutated tumor suppressor (TSP) gene. At the same time, CIN is costly for the cell because it destroys the genome and therefore compromises clonal expansion. Here, we use mathematical models to determine whether CIN can accelerate the generation and expansion of TSP(-/-) cells in the context of this tradeoff. Comparing cells with different degrees of CIN, we find that the emergence and growth of TSP(-/-) cells is optimized if the rate of chromosome loss is of the order of 10(-3) to 10(-2). This result is very robust, is independent of parameter values, and coincides with experimental measures using colon cancer cell lines. However, if we consider all of the steps in the pathway, including the generation of the CIN phenotype from stable cells, then it turns out that the emergence and growth of TSP(-/-) cells is never accelerated by CIN. Therefore, CIN does not arise because it accelerates the accumulation of adaptive mutations. Instead, it arises for other reasons, such as environmental factors, and is subsequently fine-tuned by selection to minimize the time to further cancer progression by means of the inactivation of TSP genes.

Entities:  

Mesh:

Year:  2004        PMID: 15105448      PMCID: PMC406458          DOI: 10.1073/pnas.0401943101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  The spindle checkpoint.

Authors:  A Amon
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

2.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Characterization of sporadic colon cancer by patterns of genomic instability.

Authors:  Ajay Goel; Christian N Arnold; Donna Niedzwiecki; Dong K Chang; Luigi Ricciardiello; John M Carethers; Jeannette M Dowell; Linda Wasserman; Carolyn Compton; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

4.  The mutation rate and cancer.

Authors:  I P Tomlinson; M R Novelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Genetic instability in colorectal cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

6.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 7.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

8.  Genetic instability of cancer cells is proportional to their degree of aneuploidy.

Authors:  P Duesberg; C Rausch; D Rasnick; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 9.  Mutations and aneuploidy: co-conspirators in cancer?

Authors:  German Pihan; Stephen J Doxsey
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

10.  Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  21 in total

Review 1.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

2.  Crypt dynamics and colorectal cancer: advances in mathematical modelling.

Authors:  I M M van Leeuwen; H M Byrne; O E Jensen; J R King
Journal:  Cell Prolif       Date:  2006-06       Impact factor: 6.831

3.  Genetic instability and clonal expansion.

Authors:  Martin A Nowak; Franziska Michor; Yoh Iwasa
Journal:  J Theor Biol       Date:  2006-01-06       Impact factor: 2.691

Review 4.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

5.  Stress-induced mutagenesis and complex adaptation.

Authors:  Yoav Ram; Lilach Hadany
Journal:  Proc Biol Sci       Date:  2014-10-07       Impact factor: 5.349

Review 6.  Determinants and clinical implications of chromosomal instability in cancer.

Authors:  Laurent Sansregret; Bart Vanhaesebroeck; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2018-01-03       Impact factor: 66.675

7.  Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.

Authors:  Samuel F Bakhoum; Olga V Danilova; Prabhjot Kaur; Norman B Levy; Duane A Compton
Journal:  Clin Cancer Res       Date:  2011-12-15       Impact factor: 12.531

8.  Fastest time to cancer by loss of tumor suppressor genes.

Authors:  Cynthia Sanchez-Tapia; Frederic Y M Wan
Journal:  Bull Math Biol       Date:  2014-10-23       Impact factor: 1.758

9.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

Review 10.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.